We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Information on two proposed breakthrough therapies was publicized on the CDE website, separately YY-20394 tablets (linperlisib) of YL-Pharma and plinabulin concentrated solution for injection of BeyondSpring.